Discovery of new Biomarkers

Acobiom (Montpellier, France) is focused on Biomarker discovery and their use in combination with drugs to improve diagnostics and treatments. These RNA/DNA biomarkers could be applied in several activities including: treatment response prediction, treatment efficiency, disease detection and classification, patient stratification, etc.

Our approach to discover new Biomarkers

Acobiom’s approach to discover new RNA/DNA Biomarkers is based on Next-Generation Sequencing (NGS), the investigation of gene expression changes, the analyses of biological phenotypes.

These Biomarkers can be applied in several activities including:

  • patient stratification,
  • treatment response prediction,
  • assessment of drug toxicity and treatment efficiency,
  • disease detection and classification,

Biomarkers (EN)

Our approach to discover new Biomarkers

Acobiom’s approach to discover new RNA/DNA Biomarkers is based on Next-Generation Sequencing (NGS), the investigation of gene expression changes, the analyses of biological phenotypes.

(+)


Biomarqueurs (FR)

Notre approche pour découvrir de nouveaux Biomarqueurs

L’approche d’Acobiom pour la découverte de nouveaux Biomarqueurs ARN/ADN est basée sur le séquençage (NGS, Next-Generation Sequencing), l’étude de la variation de l’expression (+)